US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nextcure Inc.

4.24

+0.06001.44%

Post-market: 4.21-0.0300-0.71%19:55 EDT

Volume:282.28K

Turnover:1.18M

Market Cap:17.25M

PE:-0.28

High:4.53

Open:4.20

Low:4.01

Close:4.18

52wk High:15.74

52wk Low:1.55

Shares:4.07M

Float Shares:2.62M

Volume Ratio:0.45

T/O Rate:10.79%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-15.3195

EPS(LYR):-19.6464

ROE:-132.40%

ROA:-66.71%

PB:0.65

PE(LYR):-0.22

Loading ...

Overview Company News Filings

NextCure posts Phase 1 dose-escalation data for SIM0505 in ovarian, uterine serous cancers at ASCO 2026

Nxtc Announces Replay Available for Virtual Kol Event Discussing Asco 2026 Dose Escalation Data From Phase 1 Trial of Sim0505 for Gynecologic Cancers

THOMSON REUTERS

NextCure posts Phase 1 SIM0505 dose-escalation presentation slides

NextCure share weakness overdone, says Lucid Capital

NextCure presents Phase 1 data for SIM0505 in gynecologic cancers

NextCure posts corporate presentation highlighting SIM0505 CDH6-targeting ADC program in cancer

NextCure reports 55% response rate in Phase 1 SIM0505 trial in gynecologic cancers at ASCO 2026

NextCure Initiated at Buy by LUCID CAPITAL MARKETS

NextCure publishes corporate presentation on Phase 1 antibody-drug conjugate cancer programs

NextCure Q1 EPS $(1.87) Beats $(2.12) Estimate

NextCure Q1 net loss narrows to $9.8 million

BRIEF-NextCure Q1 Net Income USD -9.796 Million

NextCure starts Phase 1 dose optimization study of SIM0505 in platinum-resistant ovarian cancer

NextCure and Simcere Zaiming Initiate Dose Optimization for Sim0505 (Cdh6 ADC) in Gynecologic Cancers

THOMSON REUTERS

NextCure - Accelerating Development of Program by Expanding Our Clinical Site Footprint Into Canada and Europe

THOMSON REUTERS

NextCure - Accelerating Development of Program by Increasing Number of U.S. and China Trial Sites

THOMSON REUTERS

NextCure Inc expected to post a loss of $1.81 a share - Earnings Preview

NextCure announces annual shareholder meeting to be held virtually

NextCure, Simcere to present Phase 1 SIM0505 solid tumor data at ASCO 2026

NextCure wins FDA Fast Track for SIM0505 in platinum-resistant ovarian cancer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NXTC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NXTC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NXTC\",,,,,undefined,":{"symbol":"NXTC","market":"US","secType":"STK","nameCN":"Nextcure Inc.","latestPrice":4.24,"timestamp":1784923200000,"preClose":4.18,"halted":0,"volume":282275,"hourTrading":{"tag":"盘后","latestPrice":4.21,"preClose":4.24,"latestTime":"19:55 EDT","volume":1972,"amount":8147.5005,"timestamp":1784937301300,"change":-0.03,"changeRate":-0.007075,"amplitude":0.051887},"delay":0,"changeRate":0.014354066985646053,"floatShares":2616941,"shares":4069000,"eps":-15.319524,"marketStatus":"Market Closed","change":0.06,"latestTime":"07-24 16:00:00 EDT","open":4.2,"high":4.53,"low":4.0101,"amount":1177660.89735,"amplitude":0.124378,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-15.319524,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1557374400000,"exchange":"NASDAQ","adjPreClose":4.18,"preHourTrading":{"tag":"盘前","latestPrice":4.25,"preClose":4.18,"latestTime":"09:25 EDT","volume":868,"amount":3685.800552,"timestamp":1784899500026,"change":0.07,"changeRate":0.016746,"amplitude":0.07177},"postHourTrading":{"tag":"盘后","latestPrice":4.21,"preClose":4.24,"latestTime":"19:55 EDT","volume":1972,"amount":8147.5005,"timestamp":1784937301300,"change":-0.03,"changeRate":-0.007075,"amplitude":0.051887},"volumeRatio":0.45005982202727796,"impliedVol":0.7756,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NXTC\",,,,,undefined,":{"symbol":"NXTC","floatShares":2616941,"roa":"-66.71%","roe":"-132.40%","lyrEps":-19.646445,"volumeRatio":0.45005982202727796,"shares":4069000,"dividePrice":0,"high":4.53,"amplitude":0.124378,"preClose":4.18,"low":4.0101,"week52Low":1.55,"pbRate":"0.65","week52High":15.7399,"institutionHeld":0,"latestPrice":4.24,"eps":-15.319524,"divideRate":0,"volume":282275,"delay":0,"ttmEps":-15.319524,"open":4.2,"prevYearClose":14.19,"prevWeekClose":5.99,"prevMonthClose":1.6,"prevQuarterClose":1.6,"fiveDayClose":5.99,"twentyDayClose":1.65,"sixtyDayClose":9.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NXTC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-07","symbol":"NXTC","fiscalQuarterEnding":"2026/03","expectedEps":-1.85,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-1.87},{"market":"US","date":"2026-03-05","symbol":"NXTC","fiscalQuarterEnding":"2025/12","expectedEps":-2.26,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-0.81},{"market":"US","date":"2025-11-05","symbol":"NXTC","fiscalQuarterEnding":"2025/09","expectedEps":-4.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"post","actualEps":-3.22},{"market":"US","date":"2025-08-07","symbol":"NXTC","fiscalQuarterEnding":"2025/06","expectedEps":-4.62,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-11.29},{"market":"US","date":"2025-07-14","symbol":"NXTC","defaultRemindTime":1752499800000,"type":"split","dateTimestamp":1752465600000,"forFactor":12,"toFactor":1,"ratio":12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NXTC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NXTC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1762574400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NXTC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NXTC","date":"2026-07-24","current":-0.276771,"percent":0.88,"low":-3.787079,"twenty":-1.658227,"median":-0.636926,"eighty":-0.407702,"high":-0.105725,"avg":-0.960524,"sd":0.815999,"marketCap":15098561},"quantilePoints":[{"date":"2021-07-30","current":-3.043413,"twenty":-34.894035,"median":-15.108422,"eighty":-8.999074,"marketCap":191336350},{"date":"2021-08-06","current":-3.171159,"twenty":-34.11786,"median":-14.908005,"eighty":-8.92174,"marketCap":210400049},{"date":"2021-08-13","current":-3.000532,"twenty":-33.677665,"median":-14.743075,"eighty":-8.837891,"marketCap":199079311},{"date":"2021-08-20","current":-2.9173,"twenty":-33.374217,"median":-14.648264,"eighty":-8.700071,"marketCap":193557000},{"date":"2021-08-27","current":-3.087926,"twenty":-33.313366,"median":-14.54037,"eighty":-8.596004,"marketCap":204877738},{"date":"2021-09-03","current":-3.221098,"twenty":-33.275794,"median":-14.353002,"eighty":-8.480121,"marketCap":213713435},{"date":"2021-09-10","current":-3.008855,"twenty":-33.23598,"median":-14.322168,"eighty":-8.271766,"marketCap":199631542},{"date":"2021-09-17","current":-2.913138,"twenty":-33.053529,"median":-14.252792,"eighty":-7.645917,"marketCap":193280885},{"date":"2021-09-24","current":-2.933946,"twenty":-33.005428,"median":-14.202654,"eighty":-7.51019,"marketCap":194661462},{"date":"2021-10-01","current":-3.146189,"twenty":-32.890386,"median":-14.0755,"eighty":-7.344302,"marketCap":208743355},{"date":"2021-10-08","current":-3.171159,"twenty":-32.869789,"median":-13.861335,"eighty":-7.118092,"marketCap":210400049},{"date":"2021-10-15","current":-3.633099,"twenty":-32.860746,"median":-13.744915,"eighty":-6.974825,"marketCap":241048875},{"date":"2021-10-22","current":-3.441665,"twenty":-32.779509,"median":-13.705498,"eighty":-6.816478,"marketCap":228347559},{"date":"2021-10-29","current":-3.420856,"twenty":-32.730233,"median":-13.510535,"eighty":-6.034448,"marketCap":226966982},{"date":"2021-11-05","current":-3.502552,"twenty":-32.66811,"median":-13.207877,"eighty":-3.671419,"marketCap":237861814},{"date":"2021-11-12","current":-2.615727,"twenty":-32.637276,"median":-13.133676,"eighty":-3.636286,"marketCap":177636639},{"date":"2021-11-19","current":-2.359443,"twenty":-32.603797,"median":-13.002396,"eighty":-3.614328,"marketCap":160232116},{"date":"2021-11-26","current":-2.448939,"twenty":-32.599568,"median":-12.990981,"eighty":-3.604396,"marketCap":166309886},{"date":"2021-12-03","current":-2.326899,"twenty":-32.562341,"median":-12.814039,"eighty":-3.59237,"marketCap":158022018},{"date":"2021-12-10","current":-2.489619,"twenty":-32.440719,"median":-12.477277,"eighty":-3.574803,"marketCap":169072509},{"date":"2021-12-17","current":-2.379783,"twenty":-32.255361,"median":-11.921142,"eighty":-3.545774,"marketCap":161613427},{"date":"2021-12-23","current":-2.514027,"twenty":-32.089537,"median":-11.883665,"eighty":-3.530886,"marketCap":170730082},{"date":"2021-12-31","current":-2.440803,"twenty":-31.909182,"median":-11.769509,"eighty":-3.517711,"marketCap":165757362},{"date":"2022-01-07","current":-2.294355,"twenty":-31.794602,"median":-11.710643,"eighty":-3.506378,"marketCap":155811920},{"date":"2022-01-14","current":-2.310627,"twenty":-31.648466,"median":-11.598274,"eighty":-3.489605,"marketCap":156916969},{"date":"2022-01-21","current":-2.180451,"twenty":-31.463026,"median":-11.504439,"eighty":-3.473795,"marketCap":148076576},{"date":"2022-01-28","current":-2.184519,"twenty":-31.270312,"median":-11.461384,"eighty":-3.453593,"marketCap":148352838},{"date":"2022-02-04","current":-2.172315,"twenty":-31.190863,"median":-11.27246,"eighty":-3.443977,"marketCap":147524052},{"date":"2022-02-11","current":-2.086886,"twenty":-31.093821,"median":-11.17795,"eighty":-3.412312,"marketCap":141722544},{"date":"2022-02-18","current":-2.09909,"twenty":-31.029239,"median":-10.947584,"eighty":-3.353464,"marketCap":142551331},{"date":"2022-02-25","current":-2.034002,"twenty":-31.012381,"median":-10.919045,"eighty":-3.299185,"marketCap":138131135},{"date":"2022-03-04","current":-1.901853,"twenty":-30.903906,"median":-10.889639,"eighty":-3.262715,"marketCap":131967682},{"date":"2022-03-11","current":-1.961785,"twenty":-30.564854,"median":-10.825686,"eighty":-3.217769,"marketCap":136126327},{"date":"2022-03-18","current":-2.045691,"twenty":-30.468636,"median":-10.808107,"eighty":-3.180314,"marketCap":141948431},{"date":"2022-03-25","current":-2.017722,"twenty":-30.27946,"median":-10.764934,"eighty":-3.171159,"marketCap":140007730},{"date":"2022-04-01","current":-1.981763,"twenty":-30.206073,"median":-10.690732,"eighty":-3.162158,"marketCap":137512542},{"date":"2022-04-08","current":-2.105623,"twenty":-30.113715,"median":-10.627946,"eighty":-3.149121,"marketCap":146107076},{"date":"2022-04-14","current":-2.00174,"twenty":-30.083493,"median":-10.593707,"eighty":-3.137866,"marketCap":138898758},{"date":"2022-04-22","current":-1.869889,"twenty":-30.015267,"median":-10.582284,"eighty":-3.117058,"marketCap":129749738},{"date":"2022-04-29","current":-1.663262,"twenty":-29.933561,"median":-10.576523,"eighty":-3.087926,"marketCap":115412119},{"date":"2022-05-06","current":-1.435368,"twenty":-29.852185,"median":-10.553745,"eighty":-3.075441,"marketCap":105439227},{"date":"2022-05-13","current":-1.337158,"twenty":-29.771616,"median":-10.490605,"eighty":-3.062957,"marketCap":98224964},{"date":"2022-05-20","current":-1.43159,"twenty":-29.770644,"median":-10.475071,"eighty":-3.029664,"marketCap":105161755},{"date":"2022-05-27","current":-1.507136,"twenty":-29.640178,"median":-10.456712,"eighty":-3.000532,"marketCap":110711188},{"date":"2022-06-03","current":-1.575127,"twenty":-29.577676,"median":-10.433881,"eighty":-2.930617,"marketCap":115705678},{"date":"2022-06-10","current":-1.790432,"twenty":-29.513656,"median":-10.370737,"eighty":-2.89233,"marketCap":131521562},{"date":"2022-06-17","current":-1.620454,"twenty":-29.488512,"median":-10.301585,"eighty":-2.863198,"marketCap":119035337},{"date":"2022-06-24","current":-1.756437,"twenty":-29.455895,"median":-10.251231,"eighty":-2.824912,"marketCap":129024317},{"date":"2022-07-01","current":-1.699777,"twenty":-29.392293,"median":-10.19986,"eighty":-2.630372,"marketCap":124862242},{"date":"2022-07-08","current":-1.816873,"twenty":-29.327482,"median":-10.133412,"eighty":-2.540062,"marketCap":133463863},{"date":"2022-07-15","current":-1.726218,"twenty":-29.267353,"median":-10.068581,"eighty":-2.52379,"marketCap":126804544},{"date":"2022-07-22","current":-1.703555,"twenty":-29.221057,"median":-9.983688,"eighty":-2.496128,"marketCap":125139714},{"date":"2022-07-29","current":-1.624232,"twenty":-29.079772,"median":-9.932137,"eighty":-2.464397,"marketCap":119312809},{"date":"2022-08-05","current":-1.780832,"twenty":-28.947368,"median":-9.846219,"eighty":-2.440803,"marketCap":130697055},{"date":"2022-08-12","current":-1.924509,"twenty":-28.936385,"median":-9.811852,"eighty":-2.418022,"marketCap":141241615},{"date":"2022-08-19","current":-1.803518,"twenty":-28.883293,"median":-9.748914,"eighty":-2.374901,"marketCap":132361985},{"date":"2022-08-26","current":-1.663622,"twenty":-28.776985,"median":-9.725934,"eighty":-2.364325,"marketCap":122094913},{"date":"2022-09-02","current":-1.538851,"twenty":-28.698739,"median":-9.559959,"eighty":-2.328526,"marketCap":112937795},{"date":"2022-09-09","current":-1.440546,"twenty":-28.685307,"median":-9.528322,"eighty":-2.312254,"marketCap":105723095},{"date":"2022-09-16","current":-1.463232,"twenty":-28.673616,"median":-9.497799,"eighty":-2.295169,"marketCap":107388026},{"date":"2022-09-23","current":-1.122945,"twenty":-28.646583,"median":-9.444387,"eighty":-2.230894,"marketCap":82414066},{"date":"2022-09-30","current":-1.039764,"twenty":-28.558519,"median":-9.383643,"eighty":-2.193469,"marketCap":76309321},{"date":"2022-10-07","current":-1.145631,"twenty":-28.537743,"median":-9.377244,"eighty":-2.176383,"marketCap":84078997},{"date":"2022-10-14","current":-1.020859,"twenty":-28.513281,"median":-9.350036,"eighty":-2.135702,"marketCap":74921878},{"date":"2022-10-21","current":-0.903649,"twenty":-28.42673,"median":-9.335006,"eighty":-2.100397,"marketCap":66319737},{"date":"2022-10-28","current":-0.949021,"twenty":-28.352993,"median":-9.304935,"eighty":-2.086886,"marketCap":69649598},{"date":"2022-11-04","current":-0.739439,"twenty":-28.262004,"median":-9.197537,"eighty":-2.063915,"marketCap":54993581},{"date":"2022-11-11","current":-0.661014,"twenty":-28.116474,"median":-9.086124,"eighty":-2.04649,"marketCap":49160928},{"date":"2022-11-18","current":-0.556447,"twenty":-28.052158,"median":-9.067704,"eighty":-2.034742,"marketCap":41384058},{"date":"2022-11-25","current":-0.541509,"twenty":-28.027666,"median":-9.029996,"eighty":-2.025866,"marketCap":40273077},{"date":"2022-12-02","current":-0.52657,"twenty":-27.675038,"median":-8.973018,"eighty":-2.009731,"marketCap":39162095},{"date":"2022-12-09","current":-0.504163,"twenty":-27.605334,"median":-8.926895,"eighty":-1.993322,"marketCap":37495623},{"date":"2022-12-16","current":-0.474287,"twenty":-27.600864,"median":-8.882534,"eighty":-1.977767,"marketCap":35273660},{"date":"2022-12-23","current":-0.459349,"twenty":-27.565163,"median":-8.802314,"eighty":-1.962318,"marketCap":34162679},{"date":"2022-12-30","current":-0.52657,"twenty":-27.529121,"median":-8.737875,"eighty":-1.958582,"marketCap":39162095},{"date":"2023-01-06","current":-0.604996,"twenty":-27.456005,"median":-8.69062,"eighty":-1.937028,"marketCap":44994748},{"date":"2023-01-13","current":-0.601261,"twenty":-27.359955,"median":-8.626181,"eighty":-1.90966,"marketCap":44717002},{"date":"2023-01-20","current":-0.646076,"twenty":-27.246132,"median":-8.574631,"eighty":-1.905849,"marketCap":48049947},{"date":"2023-01-27","current":-0.623669,"twenty":-26.955846,"median":-8.480121,"eighty":-1.890112,"marketCap":46383475},{"date":"2023-02-03","current":-0.619934,"twenty":-26.621528,"median":-8.294387,"eighty":-1.855725,"marketCap":46105729},{"date":"2023-02-10","current":-0.634872,"twenty":-26.482469,"median":-7.977692,"eighty":-1.830429,"marketCap":47216711},{"date":"2023-02-17","current":-0.590058,"twenty":-26.415476,"median":-7.645917,"eighty":-1.805709,"marketCap":43883766},{"date":"2023-02-24","current":-0.593792,"twenty":-26.370562,"median":-7.547892,"eighty":-1.802115,"marketCap":44161512},{"date":"2023-03-03","current":-0.557475,"twenty":-26.343023,"median":-7.461178,"eighty":-1.784389,"marketCap":41661804},{"date":"2023-03-10","current":-0.553759,"twenty":-26.293765,"median":-7.344302,"eighty":-1.767869,"marketCap":41384058},{"date":"2023-03-17","current":-0.59464,"twenty":-26.246562,"median":-7.208576,"eighty":-1.729995,"marketCap":44439257},{"date":"2023-03-24","current":-0.579774,"twenty":-26.136983,"median":-7.118092,"eighty":-1.711864,"marketCap":43328276},{"date":"2023-03-31","current":-0.550042,"twenty":-26.104953,"median":-7.050229,"eighty":-1.703887,"marketCap":41106313},{"date":"2023-04-06","current":-0.546326,"twenty":-26.003804,"median":-6.933353,"eighty":-1.701432,"marketCap":40828567},{"date":"2023-04-14","current":-0.5742,"twenty":-25.708785,"median":-6.831559,"eighty":-1.688445,"marketCap":42911658},{"date":"2023-04-21","current":-0.576058,"twenty":-25.430624,"median":-6.685709,"eighty":-1.663262,"marketCap":43050530},{"date":"2023-04-28","current":-0.561192,"twenty":-25.396908,"median":-6.034448,"eighty":-1.639341,"marketCap":41939549},{"date":"2023-05-05","current":-0.591934,"twenty":-25.144034,"median":-3.755599,"eighty":-1.624232,"marketCap":44237008},{"date":"2023-05-12","current":-0.705187,"twenty":-25.135605,"median":-3.667028,"eighty":-1.620454,"marketCap":49523192},{"date":"2023-05-19","current":-0.704642,"twenty":-25.08503,"median":-3.66044,"eighty":-1.620454,"marketCap":49484904},{"date":"2023-05-22","current":-0.713441,"twenty":-25.034456,"median":-3.653853,"eighty":-1.616864,"marketCap":50102839},{"date":"2023-06-09","current":-0.701551,"twenty":-24.933307,"median":-3.649461,"eighty":-1.591082,"marketCap":49267792},{"date":"2023-06-15","current":-0.642097,"twenty":-24.710778,"median":-3.636286,"eighty":-1.5824,"marketCap":45092555},{"date":"2023-06-30","current":-0.713441,"twenty":-24.538824,"median":-3.634692,"eighty":-1.577253,"marketCap":50102839},{"date":"2023-07-07","current":-0.709478,"twenty":-23.845136,"median":-3.624776,"eighty":-1.54112,"marketCap":49824490},{"date":"2023-07-21","current":-0.709478,"twenty":-23.117786,"median":-3.614328,"eighty":-1.50226,"marketCap":49824490},{"date":"2023-07-28","current":-0.681733,"twenty":-23.046872,"median":-3.602675,"eighty":-1.463703,"marketCap":47876046},{"date":"2023-08-04","current":-0.681733,"twenty":-23.006412,"median":-3.59237,"eighty":-1.440546,"marketCap":47876046},{"date":"2023-08-11","current":-0.686417,"twenty":-22.947409,"median":-3.589846,"eighty":-1.432346,"marketCap":48163144},{"date":"2023-08-18","current":-0.642772,"twenty":-22.917064,"median":-3.574803,"eighty":-1.372977,"marketCap":45100748},{"date":"2023-08-25","current":-0.61103,"twenty":-22.873232,"median":-3.566382,"eighty":-1.367642,"marketCap":42873550},{"date":"2023-09-01","current":-0.579288,"twenty":-22.836144,"median":-3.53967,"eighty":-1.334136,"marketCap":40646353},{"date":"2023-09-08","current":-0.575321,"twenty":-22.741738,"median":-3.530886,"eighty":-1.280499,"marketCap":40367953},{"date":"2023-09-15","current":-0.547547,"twenty":-22.669256,"median":-3.524299,"eighty":-1.145631,"marketCap":38419155},{"date":"2023-09-22","current":-0.531676,"twenty":-22.63216,"median":-3.517711,"eighty":-1.111602,"marketCap":37305557},{"date":"2023-09-29","current":-0.511837,"twenty":-22.606872,"median":-3.511124,"eighty":-1.06245,"marketCap":35913558},{"date":"2023-10-06","current":-0.499934,"twenty":-22.573156,"median":-3.495753,"eighty":-1.039764,"marketCap":35078359},{"date":"2023-10-13","current":-0.491998,"twenty":-22.514152,"median":-3.489166,"eighty":-1.017078,"marketCap":34521560},{"date":"2023-10-20","current":-0.519773,"twenty":-22.505723,"median":-3.473795,"eighty":-0.956583,"marketCap":36470358},{"date":"2023-10-27","current":-0.412644,"twenty":-22.45852,"median":-3.473795,"eighty":-0.946752,"marketCap":28953566},{"date":"2023-11-03","current":-0.464224,"twenty":-22.343884,"median":-3.458424,"eighty":-0.937493,"marketCap":32572762},{"date":"2023-11-10","current":-0.455431,"twenty":-22.193846,"median":-3.449988,"eighty":-0.733353,"marketCap":29856238},{"date":"2023-11-17","current":-0.497995,"twenty":-22.043808,"median":-3.444555,"eighty":-0.713441,"marketCap":32646541},{"date":"2023-11-24","current":-0.536302,"twenty":-21.990775,"median":-3.420975,"eighty":-0.709478,"marketCap":35157814},{"date":"2023-12-01","current":-0.502251,"twenty":-21.915966,"median":-3.412312,"eighty":-0.704751,"marketCap":32925571},{"date":"2023-12-08","current":-0.532046,"twenty":-21.898827,"median":-3.379374,"eighty":-0.697587,"marketCap":34878783},{"date":"2023-12-15","current":-0.497995,"twenty":-21.888712,"median":-3.327628,"eighty":-0.693366,"marketCap":32646541},{"date":"2023-12-22","current":-0.476713,"twenty":-21.839823,"median":-3.284954,"eighty":-0.68402,"marketCap":31251390},{"date":"2023-12-29","current":-0.489482,"twenty":-21.814536,"median":-3.2752,"eighty":-0.681733,"marketCap":32088481},{"date":"2024-01-05","current":-0.510764,"twenty":-21.779134,"median":-3.262715,"eighty":-0.679782,"marketCap":33483632},{"date":"2024-01-12","current":-0.497995,"twenty":-21.725188,"median":-3.241038,"eighty":-0.674514,"marketCap":32646541},{"date":"2024-01-19","current":-0.489482,"twenty":-21.681649,"median":-3.216937,"eighty":-0.673806,"marketCap":32088481},{"date":"2024-01-26","current":-0.506507,"twenty":-21.57632,"median":-3.183644,"eighty":-0.658026,"marketCap":33204602},{"date":"2024-02-02","current":-0.553327,"twenty":-21.441436,"median":-3.179482,"eighty":-0.643433,"marketCap":36273935},{"date":"2024-02-09","current":-0.553327,"twenty":-21.090872,"median":-3.171159,"eighty":-0.639246,"marketCap":36273935},{"date":"2024-02-16","current":-0.600147,"twenty":-21.055916,"median":-3.170771,"eighty":-0.634872,"marketCap":39343268},{"date":"2024-02-23","current":-0.646967,"twenty":-20.988483,"median":-3.161988,"eighty":-0.634872,"marketCap":42412601},{"date":"2024-03-01","current":-0.736351,"twenty":-20.905775,"median":-3.156169,"eighty":-0.634872,"marketCap":48272236},{"date":"2024-03-08","current":-0.7023,"twenty":-20.829927,"median":-3.146189,"eighty":-0.634872,"marketCap":46039994},{"date":"2024-03-15","current":-0.625686,"twenty":-20.53714,"median":-3.136752,"eighty":-0.634872,"marketCap":41017449},{"date":"2024-03-22","current":-0.747367,"twenty":-20.432162,"median":-3.118071,"eighty":-0.631138,"marketCap":46877085},{"date":"2024-03-28","current":-0.860806,"twenty":-20.43181,"median":-3.100505,"eighty":-0.631672,"marketCap":53992357},{"date":"2024-04-05","current":-0.9609,"twenty":-20.149891,"median":-3.087926,"eighty":-0.634259,"marketCap":60270538},{"date":"2024-04-12","current":-0.836339,"twenty":-19.944111,"median":-3.078546,"eighty":-0.634872,"marketCap":52457690},{"date":"2024-04-19","current":-0.700191,"twenty":-19.91028,"median":-3.074798,"eighty":-0.634872,"marketCap":43918063},{"date":"2024-04-26","current":-0.575316,"twenty":-19.842002,"median":-3.07128,"eighty":-0.634872,"marketCap":36085542},{"date":"2024-05-03","current":-0.664512,"twenty":-19.805649,"median":-3.045609,"eighty":-0.631672,"marketCap":41680200},{"date":"2024-05-10","current":-0.75492,"twenty":-19.788888,"median":-3.029664,"eighty":-0.633645,"marketCap":48114057},{"date":"2024-05-17","current":-0.724196,"twenty":-19.653566,"median":-2.983885,"eighty":-0.633645,"marketCap":46155926},{"date":"2024-05-24","current":-0.70664,"twenty":-18.732713,"median":-2.902734,"eighty":-0.633645,"marketCap":45036995},{"date":"2024-05-31","current":-0.693473,"twenty":-18.26814,"median":-2.86736,"eighty":-0.633645,"marketCap":44197796},{"date":"2024-06-07","current":-0.539855,"twenty":-18.148679,"median":-2.761182,"eighty":-0.627403,"marketCap":34407145},{"date":"2024-06-14","current":-0.702251,"twenty":-18.173329,"median":-2.562843,"eighty":-0.627403,"marketCap":44757262},{"date":"2024-06-21","current":-0.65836,"twenty":-18.19798,"median":-2.526231,"eighty":-0.627403,"marketCap":41959933},{"date":"2024-06-28","current":-0.719807,"twenty":-18.26814,"median":-2.514027,"eighty":-0.627343,"marketCap":45876193},{"date":"2024-07-05","current":-0.689084,"twenty":-18.26814,"median":-2.489619,"eighty":-0.627343,"marketCap":43918063},{"date":"2024-07-12","current":-0.700056,"twenty":-18.26814,"median":-2.440803,"eighty":-0.627343,"marketCap":44617395},{"date":"2024-07-15","current":-0.724196,"twenty":-18.26814,"median":-2.440803,"eighty":-0.627343,"marketCap":46155926},{"date":"2024-08-02","current":-0.70664,"twenty":-14.460919,"median":-2.375715,"eighty":-0.625686,"marketCap":45036995},{"date":"2024-08-09","current":-0.71219,"twenty":-14.245084,"median":-2.353341,"eighty":-0.625686,"marketCap":43642310},{"date":"2024-08-16","current":-0.71219,"twenty":-13.890499,"median":-2.320797,"eighty":-0.625686,"marketCap":43642310},{"date":"2024-08-23","current":-0.721321,"twenty":-13.207877,"median":-2.296389,"eighty":-0.625686,"marketCap":44201827},{"date":"2024-08-30","current":-0.716756,"twenty":-13.002396,"median":-2.223165,"eighty":-0.625686,"marketCap":43922068},{"date":"2024-09-06","current":-0.657406,"twenty":-12.819746,"median":-2.186553,"eighty":-0.625686,"marketCap":40285209},{"date":"2024-09-13","current":-0.630015,"twenty":-11.925438,"median":-2.170281,"eighty":-0.623669,"marketCap":38606659},{"date":"2024-09-20","current":-0.652841,"twenty":-11.769509,"median":-2.105623,"eighty":-0.623669,"marketCap":40005451},{"date":"2024-09-27","current":-0.64371,"twenty":-11.598274,"median":-2.086886,"eighty":-0.623669,"marketCap":39445934},{"date":"2024-10-04","current":-0.598057,"twenty":-11.461287,"median":-2.062478,"eighty":-0.621429,"marketCap":36648350},{"date":"2024-10-11","current":-0.630015,"twenty":-11.143583,"median":-2.043693,"eighty":-0.618966,"marketCap":38606659},{"date":"2024-10-18","current":-0.661972,"twenty":-10.913337,"median":-2.027788,"eighty":-0.618966,"marketCap":40564968},{"date":"2024-10-25","current":-0.616319,"twenty":-10.822012,"median":-2.005736,"eighty":-0.617173,"marketCap":37767384},{"date":"2024-10-31","current":-0.616319,"twenty":-10.764934,"median":-1.98954,"eighty":-0.617173,"marketCap":37767384},{"date":"2024-11-08","current":-0.602623,"twenty":-10.621175,"median":-1.977767,"eighty":-0.616319,"marketCap":36928108},{"date":"2024-11-15","current":-0.640617,"twenty":-10.582284,"median":-1.960778,"eighty":-0.616319,"marketCap":37487625},{"date":"2024-11-22","current":-0.617393,"twenty":-10.508965,"median":-1.933817,"eighty":-0.616319,"marketCap":36128622},{"date":"2024-11-29","current":-0.559961,"twenty":-10.470905,"median":-1.905849,"eighty":-0.612684,"marketCap":32767820},{"date":"2024-12-06","current":-0.521673,"twenty":-10.415615,"median":-1.89048,"eighty":-0.609811,"marketCap":30527285},{"date":"2024-12-13","current":-0.521673,"twenty":-10.270434,"median":-1.848889,"eighty":-0.607188,"marketCap":30527285},{"date":"2024-12-20","current":-0.454669,"twenty":-10.143923,"median":-1.824428,"eighty":-0.604996,"marketCap":26606349},{"date":"2024-12-27","current":-0.396185,"twenty":-10.050315,"median":-1.805541,"eighty":-0.602075,"marketCap":23183933},{"date":"2025-01-03","current":-0.393409,"twenty":-9.932137,"median":-1.794209,"eighty":-0.601294,"marketCap":23021494},{"date":"2025-01-10","current":-0.407288,"twenty":-9.818652,"median":-1.777211,"eighty":-0.600815,"marketCap":23833688},{"date":"2025-01-17","current":-0.366607,"twenty":-9.72937,"median":-1.735661,"eighty":-0.598057,"marketCap":21453119},{"date":"2025-01-24","current":-0.410638,"twenty":-9.543598,"median":-1.712997,"eighty":-0.59464,"marketCap":24029734},{"date":"2025-01-31","current":-0.382401,"twenty":-9.475453,"median":-1.703555,"eighty":-0.59153,"marketCap":22377340},{"date":"2025-02-07","current":-0.378094,"twenty":-9.382261,"median":-1.696,"eighty":-0.587316,"marketCap":22125280},{"date":"2025-02-14","current":-0.346793,"twenty":-9.348751,"median":-1.663442,"eighty":-0.58313,"marketCap":20293643},{"date":"2025-02-21","current":-0.359428,"twenty":-9.263694,"median":-1.646895,"eighty":-0.580377,"marketCap":21033019},{"date":"2025-02-28","current":-0.368043,"twenty":-9.078223,"median":-1.623756,"eighty":-0.579114,"marketCap":21537139},{"date":"2025-03-07","current":-0.341194,"twenty":-8.986591,"median":-1.61447,"eighty":-0.575321,"marketCap":19965965},{"date":"2025-03-14","current":-0.362325,"twenty":-8.893686,"median":-1.569098,"eighty":-0.574813,"marketCap":20164812},{"date":"2025-03-21","current":-0.309184,"twenty":-8.741312,"median":-1.507136,"eighty":-0.570766,"marketCap":17207306},{"date":"2025-03-28","current":-0.267063,"twenty":-8.611093,"median":-1.463232,"eighty":-0.568625,"marketCap":14863147},{"date":"2025-04-04","current":-0.199782,"twenty":-8.476684,"median":-1.440546,"eighty":-0.565874,"marketCap":11118653},{"date":"2025-04-11","current":-0.135872,"twenty":-7.959595,"median":-1.420259,"eighty":-0.561581,"marketCap":7561804},{"date":"2025-04-17","current":-0.168481,"twenty":-7.569005,"median":-1.371154,"eighty":-0.560181,"marketCap":9376637},{"date":"2025-04-25","current":-0.210853,"twenty":-7.344302,"median":-1.337158,"eighty":-0.559654,"marketCap":11734800},{"date":"2025-05-02","current":-0.24155,"twenty":-7.11206,"median":-1.276722,"eighty":-0.557475,"marketCap":13443208},{"date":"2025-05-09","current":-0.217729,"twenty":-6.877785,"median":-1.134288,"eighty":-0.555287,"marketCap":10782573},{"date":"2025-05-16","current":-0.23336,"twenty":-6.545868,"median":-1.070012,"eighty":-0.553759,"marketCap":11556678},{"date":"2025-05-23","current":-0.281561,"twenty":-3.703039,"median":-1.051107,"eighty":-0.550181,"marketCap":13943749},{"date":"2025-05-30","current":-0.281165,"twenty":-3.644191,"median":-1.027629,"eighty":-0.549404,"marketCap":13924114},{"date":"2025-06-06","current":-0.280655,"twenty":-3.614328,"median":-0.99204,"eighty":-0.545892,"marketCap":13898869},{"date":"2025-06-13","current":-0.368335,"twenty":-3.59237,"median":-0.956583,"eighty":-0.542337,"marketCap":18241039},{"date":"2025-06-20","current":-0.256356,"twenty":-3.57483,"median":-0.939569,"eighty":-0.54061,"marketCap":12695516},{"date":"2025-06-27","current":-0.260547,"twenty":-3.545774,"median":-0.894462,"eighty":-0.536302,"marketCap":12903087},{"date":"2025-07-03","current":-0.24684,"twenty":-3.530008,"median":-0.849684,"eighty":-0.53175,"marketCap":12224273},{"date":"2025-07-11","current":-0.265192,"twenty":-3.51332,"median":-0.810837,"eighty":-0.528292,"marketCap":13133099},{"date":"2025-07-18","current":-0.242139,"twenty":-3.491362,"median":-0.74804,"eighty":-0.526798,"marketCap":11991446},{"date":"2025-07-25","current":-0.248275,"twenty":-3.472038,"median":-0.736291,"eighty":-0.52374,"marketCap":12295323},{"date":"2025-08-01","current":-0.268031,"twenty":-3.449479,"median":-0.731713,"eighty":-0.523533,"marketCap":13273713},{"date":"2025-08-08","current":-0.275326,"twenty":-3.419147,"median":-0.729434,"eighty":-0.521673,"marketCap":13634994},{"date":"2025-08-15","current":-0.226104,"twenty":-3.369274,"median":-0.724196,"eighty":-0.519376,"marketCap":13775811},{"date":"2025-08-22","current":-0.224448,"twenty":-3.275977,"median":-0.720564,"eighty":-0.512543,"marketCap":13674922},{"date":"2025-08-29","current":-0.225326,"twenty":-3.23705,"median":-0.71609,"eighty":-0.510764,"marketCap":13728444},{"date":"2025-09-05","current":-0.216981,"twenty":-3.183644,"median":-0.713441,"eighty":-0.507869,"marketCap":13219983},{"date":"2025-09-12","current":-0.238942,"twenty":-3.171159,"median":-0.710254,"eighty":-0.502633,"marketCap":14558038},{"date":"2025-09-19","current":-0.248456,"twenty":-3.161988,"median":-0.708059,"eighty":-0.500566,"marketCap":15137683},{"date":"2025-09-26","current":-0.253876,"twenty":-3.144524,"median":-0.703851,"eighty":-0.497995,"marketCap":15467915},{"date":"2025-10-03","current":-0.252699,"twenty":-3.117868,"median":-0.702251,"eighty":-0.496147,"marketCap":15396196},{"date":"2025-10-10","current":-0.286819,"twenty":-3.087926,"median":-0.700124,"eighty":-0.489482,"marketCap":17474998},{"date":"2025-10-17","current":-0.382132,"twenty":-3.07358,"median":-0.697587,"eighty":-0.489482,"marketCap":23282157},{"date":"2025-10-24","current":-0.390477,"twenty":-3.042328,"median":-0.693548,"eighty":-0.48827,"marketCap":23790617},{"date":"2025-10-31","current":-0.538059,"twenty":-3.00719,"median":-0.691844,"eighty":-0.485279,"marketCap":32782347},{"date":"2025-11-07","current":-0.453007,"twenty":-2.916468,"median":-0.687751,"eighty":-0.483534,"marketCap":26279400},{"date":"2025-11-14","current":-0.450864,"twenty":-2.87069,"median":-0.681733,"eighty":-0.477564,"marketCap":26155062},{"date":"2025-11-21","current":-0.537929,"twenty":-2.83157,"median":-0.679358,"eighty":-0.474718,"marketCap":31205782},{"date":"2025-11-28","current":-0.822955,"twenty":-2.635253,"median":-0.677199,"eighty":-0.474718,"marketCap":47740442},{"date":"2025-12-05","current":-0.743521,"twenty":-2.53274,"median":-0.677199,"eighty":-0.474718,"marketCap":43132422},{"date":"2025-12-12","current":-0.665256,"twenty":-2.5124,"median":-0.674514,"eighty":-0.474718,"marketCap":38592167},{"date":"2025-12-19","current":-0.624955,"twenty":-2.467652,"median":-0.673806,"eighty":-0.474718,"marketCap":36254275},{"date":"2025-12-26","current":-0.747026,"twenty":-2.440803,"median":-0.672773,"eighty":-0.474718,"marketCap":43335717},{"date":"2026-01-02","current":-0.857506,"twenty":-2.419649,"median":-0.672773,"eighty":-0.474718,"marketCap":49744761},{"date":"2026-01-09","current":-0.821248,"twenty":-2.371647,"median":-0.672773,"eighty":-0.474718,"marketCap":47641389},{"date":"2026-01-16","current":-0.777738,"twenty":-2.345612,"median":-0.672773,"eighty":-0.474718,"marketCap":45117342},{"date":"2026-01-23","current":-0.764443,"twenty":-2.322017,"median":-0.672773,"eighty":-0.474718,"marketCap":44346105},{"date":"2026-01-30","current":-0.629684,"twenty":-2.297609,"median":-0.671527,"eighty":-0.474718,"marketCap":36528570},{"date":"2026-02-06","current":-0.670172,"twenty":-2.226826,"median":-0.670824,"eighty":-0.474718,"marketCap":38877336},{"date":"2026-02-13","current":-0.800097,"twenty":-2.183705,"median":-0.670661,"eighty":-0.474718,"marketCap":46414422},{"date":"2026-02-20","current":-0.86234,"twenty":-2.171501,"median":-0.670661,"eighty":-0.474718,"marketCap":50025211},{"date":"2026-02-27","current":-0.785594,"twenty":-2.105623,"median":-0.670661,"eighty":-0.474718,"marketCap":45573073},{"date":"2026-03-06","current":-0.77109,"twenty":-2.086886,"median":-0.670661,"eighty":-0.474718,"marketCap":44731723},{"date":"2026-03-13","current":-0.861986,"twenty":-2.062478,"median":-0.670661,"eighty":-0.474718,"marketCap":48136743},{"date":"2026-03-20","current":-0.642664,"twenty":-2.044892,"median":-0.670359,"eighty":-0.474718,"marketCap":35888932},{"date":"2026-03-27","current":-0.645852,"twenty":-2.02894,"median":-0.665688,"eighty":-0.474718,"marketCap":36066953},{"date":"2026-04-02","current":-0.671354,"twenty":-2.012928,"median":-0.664592,"eighty":-0.474718,"marketCap":37491117},{"date":"2026-04-10","current":-0.714709,"twenty":-1.991809,"median":-0.664592,"eighty":-0.474718,"marketCap":39912196},{"date":"2026-04-17","current":-0.70132,"twenty":-1.977767,"median":-0.664592,"eighty":-0.474718,"marketCap":39164510},{"date":"2026-04-24","current":-0.790579,"twenty":-1.961584,"median":-0.664253,"eighty":-0.474718,"marketCap":44149084},{"date":"2026-05-01","current":-0.587196,"twenty":-1.935445,"median":-0.661944,"eighty":-0.474718,"marketCap":32791376},{"date":"2026-05-08","current":-0.657634,"twenty":-1.905849,"median":-0.659868,"eighty":-0.474718,"marketCap":36724909},{"date":"2026-05-15","current":-0.67645,"twenty":-1.890357,"median":-0.657959,"eighty":-0.474718,"marketCap":36977438},{"date":"2026-05-22","current":-0.67315,"twenty":-1.848133,"median":-0.65482,"eighty":-0.474718,"marketCap":36797061},{"date":"2026-05-29","current":-0.422369,"twenty":-1.824428,"median":-0.650654,"eighty":-0.472457,"marketCap":23088352},{"date":"2026-06-05","current":-0.210524,"twenty":-1.805136,"median":-0.649291,"eighty":-0.464227,"marketCap":11508100},{"date":"2026-06-12","current":-0.147169,"twenty":-1.788921,"median":-0.646678,"eighty":-0.459349,"marketCap":8044847},{"date":"2026-06-18","current":-0.145372,"twenty":-1.77346,"median":-0.645432,"eighty":-0.454618,"marketCap":7946611},{"date":"2026-06-26","current":-0.109029,"twenty":-1.718664,"median":-0.642772,"eighty":-0.440312,"marketCap":5959958},{"date":"2026-07-02","current":-0.128852,"twenty":-1.711109,"median":-0.642097,"eighty":-0.425954,"marketCap":7043587},{"date":"2026-07-10","current":-0.132156,"twenty":-1.701432,"median":-0.639145,"eighty":-0.422369,"marketCap":7224192},{"date":"2026-07-17","current":-0.407702,"twenty":-1.688445,"median":-0.639145,"eighty":-0.413334,"marketCap":22286632},{"date":"2026-07-24","current":-0.276207,"twenty":-1.658227,"median":-0.636926,"eighty":-0.407702,"marketCap":15098561}],"updateTime":1785064983414},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NXTC\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640152426","title":"NextCure posts Phase 1 dose-escalation data for SIM0505 in ovarian, uterine serous cancers at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640152426","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640152426?lang=en_us&edition=fundamental","pubTime":"2026-06-04 20:01","pubTimestamp":1780574498,"startTime":"0","endTime":"0","summary":"NextCure flagged replay availability for a virtual KOL event on SIM0505, following presentation of Phase 1 dose-escalation data at ASCO 2026.Results were already presented at ASCO on June 1, 2026, marking the first disclosed clinical efficacy signals for the program.Discussion highlighted early signs of anti-tumor activity in ovarian cancer, uterine serous carcinoma, where treatment options remain limited.SIM0505 is an investigational antibody-drug conjugate targeting Cadherin-6, positioning it as a potential new entrant in gynecologic oncology.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL5lXfrW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","NXTC","LU2210149790.SGD","SG9999014005.SGD","IE00B3QW5Z07.USD","SG9999014013.SGD","BK4139","BK4588","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IE00BGHQF748.EUR","LU0314104364.USD","IE00BKPKM429.USD","LU2095319765.USD","IE00BN0W2V16.EUR","BK4112","SG9999014039.USD","LU2210150020.SGD","IE00B64PRP62.GBP","NDAQ","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640439152","title":"Nxtc Announces Replay Available for Virtual Kol Event Discussing Asco 2026 Dose Escalation Data From Phase 1 Trial of Sim0505 for Gynecologic Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2640439152","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640439152?lang=en_us&edition=fundamental","pubTime":"2026-06-04 20:00","pubTimestamp":1780574402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nTUA8CSHVJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640694507","title":"NextCure posts Phase 1 SIM0505 dose-escalation presentation slides","url":"https://stock-news.laohu8.com/highlight/detail?id=2640694507","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640694507?lang=en_us&edition=fundamental","pubTime":"2026-06-02 21:34","pubTimestamp":1780407275,"startTime":"0","endTime":"0","summary":"NextCure published virtual KOL event slides with initial Phase 1 dose-escalation results for SIM0505, a CDH6-targeted antibody-drug conjugate.At therapeutic doses of 4.8-8.0 mg/kg, gynecologic cancers showed a 55% ORR at 12 weeks and best response.Ovarian cancer ORR was 52.9% ; uterine serous carcinoma ORR was 66.7% (2/3).Across 59 patients dosed 1.6-9.6 mg/kg, grade 3 or higher TEAEs occurred in 54.2%; grade 3 or higher TRAEs occurred in 47.5%.Dose optimization started in 2Q 2026, testing 5.6, 6.4, 7.2 mg/kg every three weeks; a pivotal trial in platinum-resistant ovarian cancer is being planned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief on June 02, 202","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL7tn941:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640144329","title":"NextCure share weakness overdone, says Lucid Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2640144329","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640144329?lang=en_us&edition=fundamental","pubTime":"2026-06-02 18:10","pubTimestamp":1780395004,"startTime":"0","endTime":"0","summary":"Lucid Capital analyst Christopher Liu says NextCure’s (NXTC) SIM0505 data “were relatively encouraging,” despite the shares trading down 45%. The w...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nextcure-share-weakness-overdone-says-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nextcure-share-weakness-overdone-says-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LCID","NXTC","BK4551","BK4555","LCIZ","BK4099","LCDL","BK4596"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640917957","title":"NextCure presents Phase 1 data for SIM0505 in gynecologic cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2640917957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640917957?lang=en_us&edition=fundamental","pubTime":"2026-06-01 21:49","pubTimestamp":1780321785,"startTime":"0","endTime":"0","summary":"NextCure (NXTC) and Simcere Zaiming Pharmaceutical announced positive Phase 1 dose escalation data for SIM0505, an antibody-drug conjugate targetin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nextcure-presents-phase-1-data-for-sim0505-in-gynecologic-cancers-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nextcure-presents-phase-1-data-for-sim0505-in-gynecologic-cancers-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640515579","title":"NextCure posts corporate presentation highlighting SIM0505 CDH6-targeting ADC program in cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2640515579","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640515579?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:18","pubTimestamp":1780316338,"startTime":"0","endTime":"0","summary":"NextCure highlighted SIM0505, a CDH6-targeted TOPOi antibody-drug conjugate, as its lead program advancing toward a pivotal study.Phase 1 data showed 55% ORR in gynecologic cancers at therapeutic doses; dose escalation completed; dose optimization initiated.Dose-optimization plan targets 5.6, 6.4, 7.2 mg/kg in PROC and uterine serous carcinoma, enrolling up to 120 patients.Pivotal trial planning outlined for PROC, comparing SIM0505 with treatment of physician’s choice; n=215, expandable to 430; endpoints ORR, PFS.Development strategy includes combining US and China data, expanding sites across North America and Europe, initiating CDMO tech transfer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original con","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL3tvSBw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640959092","title":"NextCure reports 55% response rate in Phase 1 SIM0505 trial in gynecologic cancers at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640959092","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640959092?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:08","pubTimestamp":1780315724,"startTime":"0","endTime":"0","summary":"NextCure reported positive early-stage results for SIM0505, an experimental antibody-drug conjugate for gynecologic cancers, presented at ASCO 2026.The study showed meaningful tumor shrinkage signals in heavily pretreated ovarian cancer and uterine serous carcinoma patients within the targeted dose range.Safety looked manageable overall, supporting continued Phase 1 dose optimization with a strategic focus on platinum-resistant ovarian cancer.A virtual key opinion leader event is scheduled for June 2, 2026 to review the ASCO data.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief on June 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL4bg3mj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634345712","title":"NextCure Initiated at Buy by LUCID CAPITAL MARKETS","url":"https://stock-news.laohu8.com/highlight/detail?id=2634345712","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634345712?lang=en_us&edition=fundamental","pubTime":"2026-05-12 03:27","pubTimestamp":1778527620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NXTC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 11, 2026 15:27 ET (19:27 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633827170","title":"NextCure publishes corporate presentation on Phase 1 antibody-drug conjugate cancer programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2633827170","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633827170?lang=en_us&edition=fundamental","pubTime":"2026-05-08 05:11","pubTimestamp":1778188313,"startTime":"0","endTime":"0","summary":"NextCure outlined development plans for SIM0505, a CDH6-targeting antibody-drug conjugate licensed ex-China from Simcere Zaiming, with Phase 1 trials running in China and US.Initial Phase 1 summary as of April 16, 2025 showed 5 patients treated across 1.6 mg/kg (n=3) and 3.2 mg/kg (n=2), with no dose-limiting toxicities reported to date.Early activity included a partial response at 1.6 mg/kg in serous endometrial carcinoma, with a 43% reduction in target lesions at first 6-week assessment.Next milestone flagged as Phase 1 clinical data in 2Q 2026, followed by a trial progress update in 2H 2026.Presentation also highlighted LNCB74, a B7-H4-targeting MMAE ADC in Phase 1 under a 50/50 co-development partnership with LigaChem Biosciences.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpre","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL60Nyvw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633174491","title":"NextCure Q1 EPS $(1.87) Beats $(2.12) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633174491","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633174491?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:33","pubTimestamp":1778186014,"startTime":"0","endTime":"0","summary":"NextCure (NASDAQ:NXTC) reported quarterly losses of $(1.87) per share which beat the analyst consensus estimate of $(2.12) by 11.79 percent. This is a 60.21 percent increase over losses of $(4.70) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52391900/nextcure-q1-eps-1-87-beats-2-12-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"NextCure Q1 EPS $(1.87) Beats $(2.12) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633717191","title":"NextCure Q1 net loss narrows to $9.8 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633717191","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633717191?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:24","pubTimestamp":1778185471,"startTime":"0","endTime":"0","summary":"NextCure posted a net loss of $9.8 million, narrowing from $11 million a year earlier, while loss per share improved to $1.87 from $4.70.Cash, cash equivalents, and marketable securities fell to $29.7 million from $41.8 million at Dec. 31, 2025, reflecting $13.4 million used in operations, partly offset by $1.2 million of ATM equity sales.Research and development expense declined to $6.8 million from $7.9 million on lower costs tied to deprioritized programs, partly offset by SIM0505 spending.FDA granted Fast Track designation for SIM0505 in platinum-resistant ovarian cancer, with initial Phase 1 dose-escalation data slated for presentation at ASCO 2026 on June 1.Company expects existing resources to fund operations into first half of 2027 through proof-of-concept for SIM0505, while a Phase 1 update for LNCB74 is planned for second half of 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL3Kb702:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","LU2210149790.SGD","BK4112","SG9999014005.SGD","BK4139","LU2210150020.SGD","SG9999014013.SGD","IE00BN0W2T93.GBP","LU2095319765.USD","IE00BGHQF748.EUR","BK4588","NXTC","NDAQ","IE00BN0W2V16.EUR","SG9999014039.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","IE00B3QW5Z07.USD","BK4585","LU0314104364.USD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633176271","title":"BRIEF-NextCure Q1 Net Income USD -9.796 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633176271","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633176271?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:05","pubTimestamp":1778184358,"startTime":"0","endTime":"0","summary":"BRIEF-NextCure Q1 Net Income USD -9.796 Million\n\n\nMay 07 (Reuters) - NextCure Q1 basic EPS USD -1.87.\n\nQ1 income from operations USD -10.105 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLX7DE5D9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632193710","title":"NextCure starts Phase 1 dose optimization study of SIM0505 in platinum-resistant ovarian cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2632193710","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632193710?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:06","pubTimestamp":1777892810,"startTime":"0","endTime":"0","summary":"NextCure initiated dose optimization in Phase 1 study of SIM0505, antibody-drug conjugate targeting CDH6, in patients with platinum-resistant ovarian cancer.Study aims to support dose selection, reduce development risk, position program for potential registrational trials.Phase 1 results have not yet been presented; data readout slated for ASCO 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL2CZP5d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","SG9999014005.SGD","IE00BGHQF748.EUR","BK4139","NXTC","IE00B64PRP62.GBP","BK4112","IE00B3QW5Z07.USD","LU2095319765.USD","SG9999014021.USD","BK4585","IE00BKPKM429.USD","SG9999014013.SGD","NDAQ","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","BK4588","LU0314104364.USD","LU2210149790.SGD","SG9999014039.USD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632937111","title":"NextCure and Simcere Zaiming Initiate Dose Optimization for Sim0505 (Cdh6 ADC) in Gynecologic Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2632937111","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632937111?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:05","pubTimestamp":1777892714,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nFWN41H06V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632374639","title":"NextCure - Accelerating Development of Program by Expanding Our Clinical Site Footprint Into Canada and Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2632374639","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632374639?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:05","pubTimestamp":1777892714,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nFWN41H06V:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632143937","title":"NextCure - Accelerating Development of Program by Increasing Number of U.S. and China Trial Sites","url":"https://stock-news.laohu8.com/highlight/detail?id=2632143937","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632143937?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:05","pubTimestamp":1777892714,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nFWN41H06V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630399602","title":"NextCure Inc  expected to post a loss of $1.81 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2630399602","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630399602?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:21","pubTimestamp":1777292468,"startTime":"0","endTime":"0","summary":"NextCure Inc  expected to post a loss of $1.81 a share - Earnings Preview NextCure Inc NXTC.OQ NXTC.O is expected to  show no change in quarterly revenue when it reports  results on April 29 (estimate","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nL8N41A16I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630827354","title":"NextCure announces annual shareholder meeting to be held virtually","url":"https://stock-news.laohu8.com/highlight/detail?id=2630827354","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630827354?lang=en_us&edition=fundamental","pubTime":"2026-04-25 04:21","pubTimestamp":1777062080,"startTime":"0","endTime":"0","summary":"NextCure scheduled 2026 annual stockholder meeting for June 18, 2026, to be held virtually.Stockholders will vote on election of two Class I directors: Anne Borgman, M.D., John G. Houston, Ph.D.Advisory vote set on named executive officer compensation.Meeting will also consider amended and restated 2019 Omnibus Incentive Plan, including increase in shares authorized for issuance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 24, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL1SzKkH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629305320","title":"NextCure, Simcere to present Phase 1 SIM0505 solid tumor data at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2629305320","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629305320?lang=en_us&edition=fundamental","pubTime":"2026-04-21 22:15","pubTimestamp":1776780938,"startTime":"0","endTime":"0","summary":"NextCure disclosed Phase 1 findings from SIM0505, an investigational CDH6-targeting antibody-drug conjugate for advanced solid tumors, will be presented at ASCO 2026.Poster presentation is scheduled for June 1, 2026, in Gynecologic Cancer session in Chicago.Update signals continued clinical progress in NextCure collaboration with Simcere to advance SIM0505 development in solid tumors.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL3Q8Vjw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2210150020.SGD","NDAQ","LU2095319765.USD","SG9999014005.SGD","BK4588","SG9999014013.SGD","IE00BKPKM429.USD","BK4112","NXTC","BK4139","IE00BGHQF748.EUR","IE00BN0W2W23.USD","LU0314104364.USD","SG9999014039.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","LU2210149790.SGD","SG9999014021.USD","IE00BN0W2V16.EUR","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625584569","title":"NextCure wins FDA Fast Track for SIM0505 in platinum-resistant ovarian cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2625584569","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625584569?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:35","pubTimestamp":1775565344,"startTime":"0","endTime":"0","summary":"NextCure received FDA Fast Track designation for SIM0505 in platinum-resistant ovarian cancer.Phase 1 results have not yet been presented; data are scheduled for ASCO 2026.Fast Track status positions SIM0505 for a potentially faster development path in an area of high unmet need.NextCure plans to start dose-optimization work in ovarian cancer in Q2 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief on April 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDLbRX0N6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NXTC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":55,"code":"91000000","status":"200"}]}}